FDA Warns Against Concurrent Use Of Triptans With SSRIs/SNRIs
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency has received reports of serotonin syndrome caused by use of the migraine therapy class with antidepressants, according to a public health advisory.